biomarkers

Longitudinal (¹⁸F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation
Rhian S Convery, Jieqing Jiao, Mica T M Clarke, Katrina M Moore, Carolin A M Koriath, Ione O C Woollacott, Philip S J Weston, Roger Gunn, Ilan Rabiner, David M Cash, Martin N Rossor, Jason D Warren, Nick C Fox, Sebastien Ourselin, Martina Bocchetta, Jonathan D Rohrer

Journal of Neurology, Neurosurgery & Psychiatry Jan 2020, 91 (1) 106-108; DOI: 10.1136/jnnp-2019-320904
CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics
Anna Jeppsson, Carsten Wikkelsö, Kaj Blennow, Henrik Zetterberg, Radu Constantinescu, Anne M Remes, Sanna-Kaisa Herukka, Tuomas Rauramaa, Katarina Nagga, Ville Leinonen, Mats Tullberg

Journal of Neurology, Neurosurgery & Psychiatry Oct 2019, 90 (10) 1117-1123; DOI: 10.1136/jnnp-2019-320826
I05 Sustained mutant huntingtin lowering in the brain and cerebrospinal fluid of huntington disease minipigs mediated by AAV5-MIHTT gene therapy
Astrid Valls, Cynthia Brouwers, Roberta Pintauro, Jolanda Snapper, Bozena Bohuslavova, Marina Sogorb-Gonzalez, Valentina Fodale, Alberto Bresciani, Zdenka Ellederova, Bas Blits, Jan Motlik, Sander van Deventer, Melvin Evers, Pavlina Konstantinova

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A89-A90; DOI: 10.1136/jnnp-2018-EHDN.241
A31 The development of translational biomarkers of neuroinflammation in a mouse model of huntington’s disease
Laura Riggall, Bernard Siow, Xavier Golay, Gillian Bates

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A11; DOI: 10.1136/jnnp-2018-EHDN.29
F22 Robust biomarkers of huntington’s disease progression: observations from the track-hd, predict-hd and image-hd studies
Peter A Wijeratne, Eileanoir B Johnson, Sarah Gregory, Amrita Mohan, Cristina Sampaio, Rachael I Scahill, Sarah J Tabrizi, Daniel C Alexander

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A47; DOI: 10.1136/jnnp-2018-EHDN.126
A11 Skin fibroblasts from huntington´s disease patients show distinct signature of MIRNAS expression along disease progression
Veronica Brito, Ruben Fernandez-Santiago, Mario Ezquerra, Esther Sieiro, Jesus Perez-Perez, Jaime Kulisevsky, Silvia Gines

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A4-A5; DOI: 10.1136/jnnp-2018-EHDN.11
A07 A comparative study on blood and brain hd signatures: comparing mouse and human hd gene expression data
Eleni Mina, Lodewijk Toonen, Elsa Kuijper, Melvin Evers, Marco Roos, Willeke van Roon-Mom

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A3; DOI: 10.1136/jnnp-2018-EHDN.7
Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
Jan Kassubek, Hans-Peter Müller, Kelly Del Tredici, Dorothée Lulé, Martin Gorges, Heiko Braak, Albert C Ludolph

Journal of Neurology, Neurosurgery & Psychiatry Apr 2018, 89 (4) 374-381; DOI: 10.1136/jnnp-2017-316365
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
Tanya Simuni, Chelsea Caspell-Garcia, Christopher S Coffey, Daniel Weintraub, Brit Mollenhauer, Shirley Lasch, Caroline M Tanner, Danna Jennings, Karl Kieburtz, Lana M Chahine, Kenneth Marek

Journal of Neurology, Neurosurgery & Psychiatry Jan 2018, 89 (1) 78-88; DOI: 10.1136/jnnp-2017-316213
Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers
Edwin Jabbari, Henrik Zetterberg, Huw R Morris

Journal of Neurology, Neurosurgery & Psychiatry Oct 2017, 88 (10) 883-888; DOI: 10.1136/jnnp-2017-315857

Main menu

biomarkers

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

biomarkers

Pages